Global Alzheimer’s Disease Diagnostics Market Overview
Alzheimer’s refers
to a neurological disorder that causes problems with memory, thinking, and behaviour.
The symptoms usually worsen over time and intervene with the successful
execution of daily tasks. With the rising prevalence of numerous
neurodegenerative diseases. Many other factors are driving the global
Alzheimer’s disease diagnostic market. With a rapid rise in the geriatric
population, the prevalence of Alzheimer’s is also seen catching ascension. Such
rise is inducing high demand for efficient diagnostic procedures, leading to an
upsurge in the global Alzheimer’s disease diagnostic market.
Further, the
development of effective biomarker technologies for the improvement of the
development process is also seen impacting the global Alzheimer’s
Disease diagnostics market. Even though the
global Alzheimer’s disease diagnostic market is witnessing propulsion in
growth, some factors are acting as hindrances for the same. Lack of awareness
coupled with low penetration of advanced diagnostic technologies in
underdeveloped regions is estimated to restrain the market from growing faster.
Key Players
The global Alzheimer’s
disease diagnostic market players include Eli Lilly and Company (the
U.K.), TauRx (Republic of Singapore), Alector LLC (the U.S.), Accera, Inc. (the
U.S.), Treventis Corporation (the U.S.), Neuro-Bio Ltd (the U.K.), and
Cognition Therapeutics Inc. (the U.S.).
Market Segmentation
The global
Alzheimer’s disease diagnostic market has been analyzed for various segments.
Such market segmentation has been carried out based on type, diagnostic test,
end-users, and region. On the basis of type, the Alzheimer’s disease diagnostic
market has been segmented into early-onset Alzheimer’s disease, familial
Alzheimer’s disease, and late-onset Alzheimer’s disease. On the basis of
diagnostic test, the Alzheimer’s disease diagnostic market has been studied for
the segments of the neurological exam, genetic testing, mini-mental state exam
(MMSE), and brain imaging. On the basis of end-users, the global Alzheimer’s
disease diagnostic market has been segmented into diagnostic centers,
hospitals, and clinics.
Industry Update
August 2018: Researchers in the Lanzhou
University and Queens College have conducted a collaborative study and
published the development of a new technique for constructing a personal brain
network using multiple structural features to improve the accurateness of
diagnosing Alzheimer’s diseases and mild cognitive impairment.
Detailed Regional Analysis
The global
Alzheimer’s disease diagnostic market is expected to reach a revenue valuation
of USD 12 billion by the end of the conjectured period. The global Alzheimer’s
disease diagnostic market has been geographically segmented into North America,
South America, Europe, Asia Pacific, and the Middle East & Africa. North
America is estimated to spearhead the global Alzheimer’s disease diagnostic
market through the assessment period. Such dominance can be owed to a high
prevalence of Alzheimer’s disease. Further, snowballing research and
development seen in the diagnostic processes to improve the accuracy of the
Diagnostics are also projected to push the Alzheimer’s disease diagnostic
market in North America to a great extent.
Europe is predicted
to follow North America and garner the second largest share in the Alzheimer’s
disease diagnostic market during the review period. The growth in this region
can be credited to the proliferating growth and development in the healthcare
sector. Moreover, growing healthcare expenditure in the region is also a vital
contributor to the growth of Alzheimer’s disease diagnostic market. Asia
Pacific is projected
to showcase the fastest growth for Alzheimer’s disease diagnostics
through the forecast period. Such growth can be accredited to the increasing
awareness of Alzheimer’s disease in the region.
About Market Research Future:
At
Market Research Future (MRFR), we enable our customers to unravel the
complexity of various industries through our Cooked Research Report (CRR),
Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have
supreme objective to provide the optimum quality market research and
intelligence services to our clients.
Contact
us:
Market
Research Future (part of Wantstats Research and Media Private Limited),
99
Hudson Street, 5Th Floor,
New
York, New York 10013
United
States of America
+1 628
258 0071
Email:
sales@marketresearchfuture.com
Comments
Post a Comment